Zobrazeno 1 - 10 of 15 pro vyhledávání: '"M H Ruwald"'
1
Type 2 diabetes is associated with higher risk of 3rd degree atrioventricular block: a Danish nationwide registry study
Autor: S Haxha, A Halili, M Malmborg, U Pedersen-Bjergaard, B T Philbert, T B Lindhardt, S Hoejberg, A M Schjerning, M H Ruwald, G H Gislason, C Torp-Pedersen, C N Bang
Publikováno v: European Heart Journal. 43
Background Type 2 diabetes (T2DM) is suggested to affect the function of the cardiomyocytes and electrical pathways which could cause conduction abnormalities and cardiac arrhythmias, such as 3rd degree atrioventricular block. The association of T2DM
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::47aec50c8c4615e4ee81027945fb09dc
https://doi.org/10.1093/eurheartj/ehac544.647
Zobrazit plný text záznamu
2
Amiodarone treatment in atrial fibrillation and the risk of incident cancers: A nationwide observational study
Autor: Morten Lock Hansen, Frederik Dalgaard, Jannik Langtved Pallisgaard, Gunnar Gislason, Jonathan P. Piccini, Maria D'Souza, Peter Vestergaard Rasmussen, Christian Torp-Pedersen, M. H. Ruwald
Publikováno v: Rasmussen, P V, Dalgaard, F, Gislason, G H, Torp-Pedersen, C, Piccini, J, D'Souza, M, Ruwald, M H, Pallisgaard, J L & Hansen, M L 2020, ' Amiodarone treatment in atrial fibrillation and the risk of incident cancers : a nationwide observational study ', Heart Rhythm, vol. 17, no. 4, pp. 560-566 . https://doi.org/10.1016/j.hrthm.2019.11.025
Background: In observational studies, case reports, and animal studies, amiodarone has been associated with incident cancer. Objective: The purpose of this study was to examine whether a dose–response relationship between amiodarone use and the ris
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea49ccfd12f1303b532928eb6a5e8eea
https://doi.org/10.1016/j.hrthm.2019.11.025
Zobrazit plný text záznamu
3
Treatment of Older Patients with Atrial Fibrillation by Morbidity Burden
Autor: Frederik Dalgaard, Karen P. Alexander, Sana M. Al-Khatib, Christian Torp-Pedersen, Gunnar Gislason, Renato D. Lopes, Jannik Langtved Pallisgaard, Peter Vestergaard Rasmussen, Morten Lock Hansen, M. H. Ruwald
Publikováno v: Rasmussen, P V, Pallisgaard, J L, Hansen, M L, Gislason, G H, Torp-Pedersen, C, Ruwald, M, Alexander, K P, Lopes, R D, Al-Khatib, S M & Dalgaard, F 2022, ' Treatment of Older Patients with Atrial Fibrillation by Morbidity Burden ', European heart journal. Quality of care & clinical outcomes, vol. 8, no. 1, qcaa070, pp. 23–30 . https://doi.org/10.1093/ehjqcco/qcaa070
Aims Older patients with atrial fibrillation (AF) are at risk of adverse outcomes, which is accentuated by comorbidities. We sought to examine the association between morbidity burden and the treatment of older AF patients. Methods and results Using
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afa7eb8727688d30218321b4a458bb5e
https://vbn.aau.dk/da/publications/7fea8881-94cf-439e-b58a-ec3ce9bede93
Zobrazit plný text záznamu
4
Electrical cardioversion of atrial fibrillation and the risk of brady-arrhythmic events
Autor: Frederik Dalgaard, Christian Torp-Pedersen, Jannik Langtved Pallisgaard, M. H. Ruwald, Jacob Tønnesen, Peter Vestergaard Rasmussen, Morten Lock Hansen, Paul Blanche, Gunnar Gislason
Publikováno v: Rasmussen, P V, Blanche, P, Dalgaard, F, Gislason, G H, Torp-Pedersen, C, Tønnesen, J, Ruwald, M H, Pallisgaard, J L & Hansen, M L 2022, ' Electrical cardioversion of atrial fibrillation and the risk of brady-arrhythmic events ', American Heart Journal, vol. 244, pp. 42-49 . https://doi.org/10.1016/j.ahj.2021.10.182
Background Electrical cardioversion (ECV) is a common procedure for terminating atrial fibrillation (AF). ECV is associated with brady-arrhythmic events, however, the age-specific risks of clinically significant brady-arrhythmic events are unknown. M
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::713b7dd4c9c9fe0ec4b7e97deaa99173
https://pubmed.ncbi.nlm.nih.gov/34666012
Zobrazit plný text záznamu
5
Anti-arrhythmic drugs confer increased risks of bradyarrhythmia in patients undergoing direct current cardioversion for atrial fibrillation
Autor: Frederik Dalgaard, Torp-Pedersen Ct, Jannik Langtved Pallisgaard, M. H. Ruwald, Morten Lock Hansen, Peter Vestergaard Rasmussen, G. H. Gislason
Publikováno v: European Heart Journal. 41
Background Bradyarrhythmia is a known complication to direct current cardioversion (DC-cardioversion) in patients with atrial fibrillation (AF). However, whether concomitant treatment with anti-arrhythmic drugs (AADs) is associated with an increased
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::120bc3dcccb4b98c9d93d9882ac142c5
https://doi.org/10.1093/ehjci/ehaa946.0554
Zobrazit plný text záznamu
6
Diabetes mellitus is associated with higher risk of third degree atrioventricular block – a Danish nationwide registry study
Autor: Torp-Pedersen Ct, Anne-Marie Schjerning, Ulrik Pedersen-Bjergaard, S Hoejberg, S Haxha, M. H. Ruwald, T. B. Lindhardt, G. H. Gislason, Casper N. Bang, B T Philbert
Publikováno v: European Heart Journal. 41
Background Diabetes mellitus (DM) is a risk factor for cardiovascular disease and sudden cardiac death. Increasing evidence shows that DM may be associated with electric disturbances including arrhythmias and atrioventricular block (AVB). However, th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::280a115e1fe1465ce43ee9582bfa6fe9
https://doi.org/10.1093/ehjci/ehaa946.0360
Zobrazit plný text záznamu
7
3153Rate versus rhythm control and mortality in atrial fibrillation patients: a Danish nationwide cohort study
Autor: G. H. Gislason, Christian Torp-Pedersen, T. B. Lindhardt, M. H. Ruwald, Frederik Dalgaard, Jannik Langtved Pallisgaard, Sana M. Al-Khatib
Publikováno v: European Heart Journal. 40
Background Treatment of AF patients with rate or rhythm drug therapy have shown no difference in mortality in clinical trials. However, the generalizability of these trials to real-world populations can be questioned. Purpose We aimed to investigate
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::02ccd594810c66823e7003857500173b
https://doi.org/10.1093/eurheartj/ehz745.0041
Zobrazit plný text záznamu
8
P4774Older patients with atrial fibrillation and comorbidities are less likely to be treated with oral anticoagulation: insights from a nationwide study
Autor: G. H. Gislason, M. H. Ruwald, Christopher B. Granger, Karen P. Alexander, Sana M. Al-Khatib, Renato D. Lopes, Frederik Dalgaard, Jannik Langtved Pallisgaard, Peter Vestergaard Rasmussen, Morten Lock Hansen
Publikováno v: European Heart Journal. 40
Background Older patients with atrial fibrillation (AF) often have multiple chronic conditions adding complexity to treatment decisions. However, regarding older AF patients, the association between multimorbidity and quality of care has not been exp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::992ae349c7ba3285669e2bc869a5ccca
https://doi.org/10.1093/eurheartj/ehz745.1150
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje